Tabid, Cyruz .

HRN: 22-63-05  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/10/2025
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
01/10/2025
01/17/2025
INTRAVENOUS
150 Mg
Every 24 Hours
PCAP-C
Waiting Final Action 
01/10/2025
CEFUROXIME 750MG (VIAL)
01/10/2025
01/17/2025
INTRAVENOUS
330 Mg
Every 8 Hours
PCAP-C
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: